Department of Health and Human Services, through National Institutes of Health, awarded Everest Biolabs, Inc. of Waltham, MA $1,153,043 under the SBIR program (Phase II), with work starting 2026-09-01 and running to 2028-08-31. It is the only SBIR or STTR award to Everest Biolabs, Inc. in the last two years. Each figure links to the federal record.
The award
| Recipient | Everest Biolabs, Inc. (Waltham, MA) |
|---|---|
| Awarding agency | Department of Health and Human Services |
| Awarding office | National Institutes of Health |
| Phase | Phase II |
| Amount obligated | $1,153,043 |
| Period of performance starts | 2026-09-01 |
| Period of performance ends | 2028-08-31 |
| Award number | R44GM165165 (grant, CFDA 93.859) |
| Assistance listing | 93.859, Biomedical Research and Research Training |
| Place of performance | Waltham, Middlesex County, MA |
| Recipient registry id (UEI) | RNK5RAFQE632 |
Want the whole picture on Everest Biolabs, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Everest Biolabs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Everest Biolabs, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What it is for
High-yield, high-purity extracellular vesicle isolation columns for high-throughput plate-based biomarker discovery and diagnosis - project summary in this direct-to-Phase II SBIR application, everest biolabs proposes to
Funding actions on this award
| Date | Action | Modification | Amount |
|---|---|---|---|
| 2026-09-01 | New | 000 | $1,153,043 |
High-yield, high-purity extracellular vesicle isolation columns for high-throughput plate-based biomarker discovery and diagnosis - project summary in this direct-to-Phase II SBIR application, everest biolabs proposes to advance the development of innovative plate-based methods and materials for isolating extracellular vesicles (evs) from biofluids using dual- mode chromatography that combines size exclusion chromatography with affinity-based depletion of common contaminants. Impact: This project is expected to deliver the first high-performance, high-throughput tool for use with fully-automated liquid handling robots that can isolate evs with the high yield, high purity, and broad size distribution required to fully realize the enormous potential of evs in rapid, reproducible, and cost-effective biomarker discovery and diagnostic testing. Virtually all living cells release evs that diffuse through extracellular spaces, transporting materials and information to other cells to affect their function. Some of these evs are eventually circulated in the blood stream or show up in saliva, urine, and other biofluids. The contents of evs, as well as the proteins embedded in and attached to the membrane surface, provide a rich source of information that can be analyzed to determine where the evs originated in the body and assess the physiological or pathological state of the originating ...
From the federal award record.
More on Everest Biolabs, Inc.
Everest Biolabs, Inc.'s Form D filing
Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Everest Biolabs, Inc.Look up Everest Biolabs, Inc. and see what is on record before you decide.
Get the free SnapshotWhere this comes from
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.
Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.